Loading...
XJPX3002
Market cap554mUSD
Jan 16, Last price  
5,160.00JPY
1D
0.00%
1Q
-5.15%
Jan 2017
32.65%
Name

Gunze Ltd

Chart & Performance

D1W1MN
XJPX:3002 chart
P/E
16.86
P/S
0.65
EPS
306.07
Div Yield, %
2.90%
Shrs. gr., 5y
-1.37%
Rev. gr., 5y
-1.14%
Revenues
132.89b
-2.31%
160,565,000,000165,697,000,000168,787,000,000165,650,000,000151,470,000,000138,116,000,000133,705,000,000136,621,000,000132,373,000,000142,425,000,000141,172,000,000138,324,000,000136,579,000,000140,521,000,000140,706,000,000140,311,000,000123,649,000,000124,314,000,000136,030,000,000132,885,000,000
Net income
5.11b
+13.51%
11,603,000,0006,220,000,0008,386,000,0006,685,000,0001,551,000,000841,000,0001,796,000,000571,000,000-1,161,000,0002,508,000,0003,215,000,000-1,201,000,0003,102,000,0003,486,000,0004,087,000,0004,387,000,0002,147,000,0002,939,000,0004,501,000,0005,109,000,000
CFO
10.41b
+480.21%
9,340,000,0005,836,000,0007,210,000,00021,224,000,00010,211,000,00016,369,000,0005,050,000,000-1,417,000,00012,343,000,00013,753,000,0009,512,000,00011,775,000,00013,832,000,0009,007,000,00011,491,000,00013,688,000,0008,595,000,0009,155,000,0001,794,000,00010,409,000,000
Dividend
Mar 28, 20250 JPY/sh

Profile

Gunze Limited engages in the functional solutions, apparel, and lifestyle creations businesses in Japan. It offers plastic films comprising shrink films, flexible multilayer sheets, functional and multilayer film tubings, opp films, and nylon films, as well as consulting services related to comprehensive package system; engineering plastics, such as small-diameter fluoro resin heat-shrinkable tubes, thin-walled fluoro resin tubes, fiber products, films and sheets, and seamless belts; electronic components, including various touch screens and functional films, as well as commissioned manufacturing services; and medical materials consisting of bioabsorbable surgical suture threads, bone fixation devices, artificial dermis, absorbable reinforcement felt, and medical stockings. The company also provides equipment for packaging and film wrapping, post-press of printing, and pharmaceuticals and cosmetics, as well as equipment for dairy, beverage, and food products; innerwear, legwear, nightwear, and home casual wear products for physical and mental relaxation; and threads and accessories, such as sewing threads for clothing, industrial materials, and automotive applications. In addition, it operates 22 Gunze sports clubs, and fitness studios, spas, and junior schools; sells plant materials and nursery trees, flowers, and gardening products; develops commercial facilities; leases shopping complexes, housing, and office buildings; and offers technology, equipment, and funds energy conservation, as well as thermal insulation materials and solar power generation systems. The company was formerly known as Gunze Silk Manufacturing Co., Ltd. and changed its name to Gunze Limited in 1967. Gunze Limited was founded in 1896 and is headquartered in Ayabe, Japan.
URL
https://www.gunze.co.jp/
IPO date
May 16, 1949
Employees
5,214
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
132,885,000
-2.31%
136,030,000
9.42%
124,314,000
0.54%
Cost of revenue
125,365,000
129,407,000
118,673,000
Unusual Expense (Income)
NOPBT
7,520,000
6,623,000
5,641,000
NOPBT Margin
5.66%
4.87%
4.54%
Operating Taxes
(650,000)
1,860,000
2,553,000
Tax Rate
28.08%
45.26%
NOPAT
8,170,000
4,763,000
3,088,000
Net income
5,109,000
13.51%
4,501,000
53.15%
2,939,000
36.89%
Dividends
(2,497,000)
(2,409,000)
(2,027,000)
Dividend yield
2.66%
3.11%
3.10%
Proceeds from repurchase of equity
(1,928,000)
(926,000)
(1,832,000)
BB yield
2.05%
1.20%
2.80%
Debt
Debt current
977,000
7,451,000
8,362,000
Long-term debt
8,321,000
8,749,000
3,477,000
Deferred revenue
Other long-term liabilities
8,385,000
9,548,000
9,891,000
Net debt
(8,353,000)
(11,991,000)
(18,442,000)
Cash flow
Cash from operating activities
10,409,000
1,794,000
9,155,000
CAPEX
(7,166,000)
(10,226,000)
(4,741,000)
Cash from investing activities
(190,000)
(5,920,000)
6,806,000
Cash from financing activities
(11,347,000)
1,007,000
(12,358,000)
FCF
9,700,000
(6,425,000)
10,970,000
Balance
Cash
10,818,000
11,547,000
14,469,000
Long term investments
6,833,000
16,644,000
15,812,000
Excess cash
11,006,750
21,389,500
24,065,300
Stockholders' equity
116,872,000
222,732,000
222,042,000
Invested Capital
127,051,250
121,673,500
109,152,700
ROIC
6.57%
4.13%
2.72%
ROCE
5.45%
4.63%
4.23%
EV
Common stock shares outstanding
17,008
17,261
17,451
Price
5,520.00
23.08%
4,485.00
19.76%
3,745.00
-9.87%
Market cap
93,884,160
21.27%
77,415,585
18.46%
65,353,995
-11.74%
EV
87,231,160
177,797,585
158,088,995
EBITDA
13,728,000
12,516,000
11,832,000
EV/EBITDA
6.35
14.21
13.36
Interest
208,000
244,000
146,000
Interest/NOPBT
2.77%
3.68%
2.59%